Scathing FTC Interim Report on PBMs Warrants Further Investigations, Immediate Action by Policymakers and Regulators
09 juil. 2024 13h13 HE
|
National Community Pharmacists Association
Alexandria, Va., July 09, 2024 (GLOBE NEWSWIRE) -- The interim report published today by the Federal Trade Commission – titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs...
AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing
03 avr. 2024 14h45 HE
|
Asthma and Allergy Foundation of America
Washington, DC, April 03, 2024 (GLOBE NEWSWIRE) -- As the leading advocacy organization focused on improving the access and affordability of asthma inhalers, the Asthma and Allergy Foundation of...
Local Pharmacies on the Brink, New Survey Reveals
27 févr. 2024 13h27 HE
|
National Community Pharmacists Association
Alexandria, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association today...
AAFA Applauds Senate Investigation into Pricing of Asthma Inhalers
09 janv. 2024 17h33 HE
|
Asthma and Allergy Foundation of America
Washington, DC, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) today applauded the announcement of a U.S. Senate Committee on Health, Education, Labor, and...
NCPA Analysis Sinks Broken-Record Argument Against PBM Regulations
14 mars 2022 14h45 HE
|
National Community Pharmacists Association
Alexandria, Va., March 14, 2022 (GLOBE NEWSWIRE) -- “Premiums will go up! Premiums will go up!” It’s what pharmacy benefit manager lobbyists squeal every time there’s a bill to regulate PBMs....
Life Sciences Investors Sound the Alarm Over Drug Price Negotiations at Incubate Panel
16 sept. 2021 12h35 HE
|
Incubate
Washington, D.C., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Yesterday, a group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against...
United States of America Drug Pricing and Reimbursement Landscape Report 2021 with Examples of 2021 Premium Rate Changes for Leading Health Insurers
29 mars 2021 07h58 HE
|
Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "United States of America (USA) Drug Pricing and Reimbursement Landscape - Thematic Research" report has been added to ResearchAndMarkets.com's...
INCUBATE RAISES CONCERN ABUT PRESIDENT TRUMP'S EXECUTIVE ORDER ON DRUG PRICING
31 juil. 2020 17h10 HE
|
Incubate
Washington, DC, July 31, 2020 (GLOBE NEWSWIRE) -- Last week, President Trump signed four Executive Orders (EO) to lower prescription drug costs. One Executive Order was discussed that would import...
How Best to Fix the US Healthcare System? For Physicians, It Starts with Affordability and Access, Says InCrowd Data
27 févr. 2020 11h00 HE
|
InCrowd, Inc
WATERTOWN, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- As healthcare reform dominates political discourse, those who know the US healthcare market perhaps best—US physicians—reported significantly...
Health Economics in Emerging Markets: Shifting Focus From Haggling to Health Outcomes
14 juin 2010 09h11 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - June 14, 2010) - Life science companies that hope to succeed in Emerging Markets must change the dialogue of negotiations to focus on positive health...